Sunday, October 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Avnets Q3 2024 Revenue Falls Below Analyst Consensus

Elaine Mendonca by Elaine Mendonca
January 31, 2024
in Breaking News
0
Technology Robotics Stock Market Today
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

As of January 31, 2024, Avnet anticipates generating a revenue between $5.55 billion and $5.85 billion in the third quarter of 2024. This projection falls short of the analyst consensus, which stands at $5.94 billion. Moreover, the company predicts that its diluted earnings per share (EPS) for Q3 will range from $1.05 to $1.15, whereas the estimated EPS is $1.34.

Comparatively, in the same period of the previous year, Avnet disclosed third quarter sales amounting to $6.5 billion and a diluted EPS of $2.03, surpassing their initial forecast. Notably, the company experienced a modest 0.3% increase in revenue for the quarter, reaching $6.51 billion, compared to $6.49 billion in the prior year.

AVT Stock Performance: A Mix of Positive and Negative Indicators on January 31, 2024

On January 31, 2024, AVT stock showcased a mix of positive and negative indicators in its performance. AVT was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive price momentum. However, the price change on that day presented a slight decline. The stock had increased by $0.27 since the market last closed, representing a rise of 0.57%. However, the stock had dropped $1.87 in pre-market trading. It is important to consider the overall market conditions and news developments throughout the trading day to gain a comprehensive understanding of AVT’s performance.

AVT Stock Shows Promising Performances with Positive Growth in Total Revenue, Net Income, and EPS in 2024

On January 31, 2024, AVT stock showed promising performances, with positive growth in total revenue, net income, and earnings per share (EPS).

AVT’s total revenue for the past year was $26.54 billion, showing a 9.16% increase compared to the previous year. However, in the first quarter of 2024, the total revenue decreased by 3.34% to $6.33 billion.

In terms of net income, AVT reported a net income of $770.83 million for the past year, indicating an 11.33% increase compared to the previous year. In the first quarter of 2024, the net income rose even further to $209.27 million, showing a significant increase of 34.79% since the last quarter.

AVT’s earnings per share (EPS) also experienced positive growth. The EPS for the past year was $8.26, representing a 19.02% increase compared to the previous year. In the first quarter of 2024, the EPS rose to $2.25, showing a substantial increase of 33.99% since the last quarter.

Overall, AVT stock exhibited impressive performances on January 31, 2024. The company’s total revenue, net income, and earnings per share all showed positive growth compared to the previous year and the last quarter. These figures suggest that AVT is on a steady growth trajectory, which may attract investors and contribute to the company’s long-term success.

Tags: AVT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Major Milestone Achieved in NORSE EIGHT Clinical Trial Investigating ONS5010 as a Potential Treatment for Neovascular AgeRelated Macular Degeneration

Finance_ Stock Charts (2)

Analyst Raises Price Target and Expresses Optimism for Axos Financials Future Growth

Stryker Introduces Groundbreaking Footprint Feature in Prophecy Surgical Planning System

Recommended

Take-Two Stock

Take-Two’s Pivotal Year: Borderlands 4 Launch Sets Stage for GTA VI

3 weeks ago
Healthcare cloud based

Analysts Remain Bullish on Evolent Health Adjust Price Targets

2 years ago
Weightless batteries

Revolutionizing Battery Technology: The Rise of Lightweight, High-Performance Energy Solutions

2 years ago
Red Cat Stock

Red Cat’s Naval Ambitions Meet Investor Skepticism

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Acquisition Speculation Fuels Viking Therapeutics Rally

Gladstone Capital Shares Face Sustained Downward Pressure

Eli Lilly Stock: A Clash of Investment Titans

Biotech Firm Ocugen Sets Ambitious Three-Year Regulatory Timeline

Wall Street Heavyweights Bet Big on Robinhood’s Transformation

Fiserv Stock: A Contrarian Bet Amid Market Pessimism

Trending

Oracle Stock
AI & Quantum Computing

Oracle’s AI Ambitions Fuel Record Rally and Investor Optimism

by Dieter Jaworski
October 5, 2025
0

Oracle Corporation is undergoing a remarkable strategic pivot, transitioning from its traditional software roots to become a...

PayPal Stock

Analyst Patience Wears Thin as PayPal Faces Critical Juncture

October 5, 2025
Reviva Pharmaceuticals Holdings Stock

Reviva Pharmaceuticals Stock Surges on Extraordinary Trading Activity

October 5, 2025
Viking Therapeutics Stock

Acquisition Speculation Fuels Viking Therapeutics Rally

October 5, 2025
Gladstone Capital Stock

Gladstone Capital Shares Face Sustained Downward Pressure

October 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Oracle’s AI Ambitions Fuel Record Rally and Investor Optimism
  • Analyst Patience Wears Thin as PayPal Faces Critical Juncture
  • Reviva Pharmaceuticals Stock Surges on Extraordinary Trading Activity

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com